arrow
B

Blossom Mak

Garvan Institute of Medical Research
H指数:9
被引数:295

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]

勘误:‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]

2025-06-110
PRE
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer

在转移性前列腺癌中使用机器学习模型对基于血液的肿瘤相关基因组和脂质组谱进行多组学整合

2023-07-012
OAAI
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)
2022-04-182
OAAI
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer

脂质组学和遗传畸变对转移性去势抵抗性前列腺癌临床结局的联合影响

2022-03-2516
OAAI
Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
2021-10-0129
OAAI